TP53 and lung carcinoma: Figure 5a,c, respectively, demonstrates significant reduction of %cell viability in H292 and H23 cells after treatment with colicin N at 5–15 μM. Although toxicity of colicin N seems to lower in p53 mutant H23 cells when compared with lung cancer cells with p53 wild type H460 and H292 cells as evidenced by the cell viability assay, nuclear staining clearly reveals DNA condensation/nuclei fragmentation presenting apoptosis in H292 and H23 cells (Figure 5b,d, respectively).